Table 1.
Inclusion and exclusion criteria
| Inclusion Criteria | |
| 1) Diagnosis of advanced non-small cell lung cancer or inoperable pancreatic cancer | |
| 2) Scheduled for systemic cancer therapy (i.e. chemotherapy, and/or targeted therapy and/or immunotherapy) | |
| i. In pancreatic cancer patients, planned systemic chemotherapy only allows of the combination of gemcitabine with nanoparticle paclitaxel. | |
| 3) Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 | |
| 4) Age ≥ 70 years | |
| 5) Body weight of 6 month ago can be confirmed | |
| 6) An expected survival of ≥3 months as judged by investigators | |
| 7) Written informed consent | |
| 8) Adequate organ function | |
| i. Hemoglobin ≥8.0 g/dl | |
| ii. Total bilirubin ≤2.0 mg/dl | |
| iii. Aspartate aminotransferase ≤150 IU/L | |
| iv. Alanine aminotransferase ≤150 IU/L | |
| v. Serum creatinine ≤2.0 mg/dl | |
| vi. Arterial oxygen saturation (SpO2) ≥ 90% or partial pressure of oxygen in arterial blood (PaO2) ≥ 60 Torr in room air | |
| vii. Resting heart rate < 120 beat per minute | |
| Exclusion criteria | |
| 1) Patients received prior chemotherapy except adjuvant chemotherapy | |
| 2) Active malignancy requiring cancer treatment including chemotherapy, radiotherapy and surgery within 3 months | |
| 3) Patients who need nursing care at following situation (based on Katz Index) | |
| i. Bathing | |
| ii. Dressing | |
| iii. Transferring | |
| iv. Feeding | |
| 4) Symptomatic brain metastasis or leptomeningeal carcinoma | |
| 5) Bone metastasis with high risk of fracture | |
| 6) Patients who are difficult to evaluate or intervene with cardiovascular disease, bone and joint disease, neuromuscular disease etc. | |
| 7) Patients who are difficult to participant due to psychiatric disorder | |
| 8) Patients who are difficult to oral intake | |
| 9) History of acute myocardial infarction, unstable angina, uncontrollable hypertension, and symptomatic sustained arrhythmia within 6 months. Stable atrial fibrillation treated with appropriate anticoagulation therapy is allowed. | |
| 10) Uncontrollable diabetes mellitus | |
| 11) Patients whose appropriate period has not passed since prior treatment | |
| i. Surgery: 7 days | |
| ii. Palliative radiation: 1 day | |
| iii. Minor surgery (i.e. biopsy): 1 day | |
| 12) Screening failure | |
| i. Patients who failed to wear the accelerometer for more than 4 days | |
| ii. Patients who could not properly handle the accelerometer | |
| iii. Patients who failed to initiate first-line therapy within 14 days of enrollment |